 |
 |
|
|
|
 |
 |
Zometa
Click
to view site
Novartis, a global leader in oncology, introduced
Zometa for the treatment of breast, prostate, renal,
and lung cancer. Zometa is an innovative treatment
for patients with bone
metastases.
Strategic Domain was assigned to the task of redesigning
the Global Zometa Web site. The key focus was on information
strategy and product positioning. To succeed, the
site needed to provide the latest product and disease
news and information available. Focused on healthcare
professionals, the site contains product details,
clinical trial reports and current news about Zometa.
To encourage ongoing relationships, the site offers
thought leader reviews, journal articles, Web casts,
disease and clinical updates and personalized patient
tools. In addition, a comprehensive resource center
is available with FAQs for physicians.
The redesigned Zometa Web site provides healthcare
professionals an up-to-date, organized and easy-to-use
portal. The site was built on Interwoven running on
an Apache, Solaris 8 platform. |
|
|
|
|
| |
|
|
